刚性胸骨固定与加速康复方案对心脏术后无阿片类镇痛的影响
该单中心回顾性病例队列研究纳入608例正中胸骨切开患者,比较实施刚性钢板固定(RPF)和加速康复方案(ERP)前后阿片类药物使用等情况。结果显示RPF+ERP-2022组住院期间阿片类药物中位用量为0 MME(对照组172.5 MME,P<.0001),出院直接回家比例达93.5%(对照组66.2%,P<.0001),且未增加再入院。
要点
- RPF+ERP-2022组住院阿片类中位用量0 MME,对照组172.5 MME(P<.0001)。
- 出院直接回家比例:对照组66.2%,RPF-only组79.6%(P=.010),RPF+ERP-2022组93.5%(P<.0001)。
- 出院阿片类处方中位数:对照组600 MME,RPF+ERP-2020和RPF+ERP-2022组均为0(P<.0001)。
核心结论
- 系统实施RPF和ERP与大型真实世界患者人群中阿片类药物使用的显著且有临床意义的减少相关。
研究设计与样本
- 单中心、回顾性、病例队列研究,比较正中胸骨切开患者(所有来者)在实施RPF或ERP前(对照组)、实施RPF但未实施ERP(RPF-only组)、以及早期RPF+ERP-2020和晚期RPF+ERP-2022实施期间的患者结局。
- 分析纳入608例正中胸骨切开患者,平均年龄65.7±10.8岁,女性占29.6%。
- 手术类型:59.2%为单纯冠状动脉旁路移植术,7.7%为单纯瓣膜手术,其余为混合/合并手术。
主要发现
- 住院期间阿片类药物给药中位数:对照组172.5 MME vs RPF+ERP-2022组0 MME(P<.0001),尽管患者报告疼痛评分相似或略降低。
- 出院直接回家比例:对照组66.2% vs RPF-only组79.6%(P=.010) vs RPF+ERP-2022组93.5%(P<.0001)。
- 出院时阿片类处方中位数:对照组600 MME vs RPF+ERP-2020组0 vs RPF+ERP-2022组0(P<.0001)。
- 出院时接受阿片类处方比例:RPF-only组86.7% vs RPF+ERP-2020组5% vs RPF+ERP-2022组4.3%(P<.0001)。
- 上述结局未伴随再入院增加。
临床怎么用
- 系统实施RPF和ERP与心脏术后阿片类药物使用显著减少相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We evaluated the individual contributions of rigid-plate fixation (RPF) and an enhanced recovery protocol (ERP) on postoperative pain, opioid use, and other outcomes after median sternotomy as they were sequentially adopted into practice. METHODS: This single-center, retrospective, case-cohort study compared outcomes between median sternotomy patients (all comers) who underwent operation before implementation of RPF or ERP ("controls"), patients closed with RPF before ERP implementation ("RPF-only"), and patients managed with RPF and ERP during early "RPF+ERP-2020" and late "RPF+ERP-2022" implementation. RESULTS: The analysis included 608 median sternotomy patients (mean age, 65.7 ± 10.8 years; 29.6% women). Of those, 59.2% were isolated coronary artery bypass grafting, 7.7% were isolated valve procedures, and the rest were mixed/concomitant procedures. Median in-hospital, postoperative opioid administration was 172.5 morphine milligram equivalents (MMEs) in the control cohort vs 0 MMEs for RPF+ERP-2022 (P < .0001), despite similar or slightly reduced patient-reported pain scores. The proportion of patients discharged directly to home was 66.2% for controls, 79.6% for RPF-only (P = .010), and 93.5% for RPF+ERP-2022 (P < .0001). Median opioids prescribed at discharge were 600 MMEs for controls and 0 for RPF+ERP-2020 and RPF+ERP-2022 (P < .0001). At discharge, 86.7% of RPF-only patients received prescription opioids vs 5% in RPF+ERP-2020 and 4.3% RPF+ERP-2022 (P < .0001). These outcomes occurred without increased readmissions. CONCLUSIONS: Systematic implementation of RPF and ERP was associated with a significant and clinically meaningful decrease in opioid use in this large, real-world patient population.
引用
- Gerdisch MW, Johns CM, Barksdale A, et al. Rigid Sternal Fixation and Enhanced Recovery for Opioid-Free Analgesia After Cardiac Surgery. Ann Thorac Surg. 2024. PMID: 39004198. doi:10.1016/j.athoracsur.2024.06.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。